NO20065582L - (1,lOB-dihydro-2-(amtnokarbonyl-fenyl)-SH-pyrazolo[1,5-C][1,3]benzoksazin-5-yl)fenylmetanonderivater som HIV-virusreplikasjonsinhibitorer - Google Patents

(1,lOB-dihydro-2-(amtnokarbonyl-fenyl)-SH-pyrazolo[1,5-C][1,3]benzoksazin-5-yl)fenylmetanonderivater som HIV-virusreplikasjonsinhibitorer

Info

Publication number
NO20065582L
NO20065582L NO20065582A NO20065582A NO20065582L NO 20065582 L NO20065582 L NO 20065582L NO 20065582 A NO20065582 A NO 20065582A NO 20065582 A NO20065582 A NO 20065582A NO 20065582 L NO20065582 L NO 20065582L
Authority
NO
Norway
Prior art keywords
benzoxazin
pyrazolo
aminocarbonyl
dihydro
phenyl
Prior art date
Application number
NO20065582A
Other languages
English (en)
Norwegian (no)
Inventor
Dominique Louis Nest Surleraux
Abdellah Tahri
Lieve Emma Jan Michiels
Koenraad Lodewijk August Acker
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of NO20065582L publication Critical patent/NO20065582L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20065582A 2004-05-04 2006-12-04 (1,lOB-dihydro-2-(amtnokarbonyl-fenyl)-SH-pyrazolo[1,5-C][1,3]benzoksazin-5-yl)fenylmetanonderivater som HIV-virusreplikasjonsinhibitorer NO20065582L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04101913 2004-05-04
US60427504P 2004-08-25 2004-08-25
PCT/EP2005/052041 WO2005105810A2 (en) 2004-05-04 2005-05-04 (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5- c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as hiv viral replication inhibitors

Publications (1)

Publication Number Publication Date
NO20065582L true NO20065582L (no) 2006-12-04

Family

ID=35058129

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065582A NO20065582L (no) 2004-05-04 2006-12-04 (1,lOB-dihydro-2-(amtnokarbonyl-fenyl)-SH-pyrazolo[1,5-C][1,3]benzoksazin-5-yl)fenylmetanonderivater som HIV-virusreplikasjonsinhibitorer

Country Status (20)

Country Link
US (1) US7326703B2 (pt)
EP (1) EP1778696B1 (pt)
JP (1) JP4929162B2 (pt)
KR (1) KR20070015547A (pt)
CN (1) CN1950380B (pt)
AP (1) AP2006003759A0 (pt)
AR (1) AR048650A1 (pt)
AT (1) ATE389660T1 (pt)
AU (1) AU2005238235B2 (pt)
BR (1) BRPI0510612A (pt)
CA (1) CA2563959C (pt)
DE (1) DE602005005490T2 (pt)
ES (1) ES2303244T3 (pt)
IL (1) IL178082A (pt)
MX (1) MXPA06012755A (pt)
NO (1) NO20065582L (pt)
PL (1) PL1778696T3 (pt)
RU (1) RU2382789C2 (pt)
WO (1) WO2005105810A2 (pt)
ZA (1) ZA200609178B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7122185B2 (en) 2002-02-22 2006-10-17 Progenics Pharmaceuticals, Inc. Anti-CCR5 antibody
TW200710091A (en) * 2005-04-11 2007-03-16 Tibotec Pharm Ltd (1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
US20070026441A1 (en) * 2005-07-22 2007-02-01 Olson William C Methods for reducing viral load in HIV-1-infected patients
WO2009000853A2 (en) * 2007-06-25 2008-12-31 Tibotec Pharmaceuticals Ltd. Combination formulations comprising darunavir and etravirine
US8592487B2 (en) * 2007-10-26 2013-11-26 Concert Pharmaceuticals, Inc. Deuterated darunavir
WO2009134401A2 (en) * 2008-04-29 2009-11-05 Progenics Pharmaceuticals, Inc. Methods of inhibiting infection by diverse subtypes of drug-resistant hiv-1

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
DE4210939A1 (de) * 1992-04-02 1993-10-07 Bayer Ag Verwendung von 7-Oxo-7H-pyrido[1,2,3-de][1,4]benzoxacin-6-carbonsäuren und -estern als Arzneimittel
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
IL111080A (en) 1993-10-01 1999-08-17 Astra Ab Method for treating a finely divided powder medicament
CN1165291C (zh) 1996-05-20 2004-09-08 詹森药业有限公司 具有改进的生物利用度的抗真菌组合物
ATE248826T1 (de) 1996-10-02 2003-09-15 Bristol Myers Squibb Pharma Co 4,4-disubstituierte 1,4-dihydro-2h-3,1-benzoxazin-2-one die anwendbar sind als hiv- reverstranskriptase-inhibitoren, zwischenprodukte und verfahren zu ihrer herstellung
HU224217B1 (hu) 1997-03-26 2005-06-28 Janssen Pharmaceutica N.V. Gombaellenes hatóanyaggal és polimerrel bevont magrészt tartalmazó pelletek
CZ289425B6 (cs) * 1998-05-20 2002-01-16 Eli Lilly And Company Imidazo[1,2-a] pyridinové sloučeniny, jejich pouľití a farmaceutický přípravek s jejich obsahem
NZ529403A (en) * 2001-04-10 2005-06-24 Pfizer Pyrazole derivatives for treating HIV

Also Published As

Publication number Publication date
EP1778696B1 (en) 2008-03-19
CA2563959C (en) 2014-07-15
AU2005238235A1 (en) 2005-11-10
US20070248624A1 (en) 2007-10-25
ZA200609178B (en) 2008-08-27
CN1950380A (zh) 2007-04-18
ES2303244T3 (es) 2008-08-01
JP4929162B2 (ja) 2012-05-09
IL178082A (en) 2012-06-28
PL1778696T3 (pl) 2008-08-29
DE602005005490D1 (de) 2008-04-30
AU2005238235B2 (en) 2011-07-07
RU2006142705A (ru) 2008-06-20
AP2006003759A0 (en) 2006-10-31
RU2382789C2 (ru) 2010-02-27
CA2563959A1 (en) 2005-11-10
AR048650A1 (es) 2006-05-10
DE602005005490T2 (de) 2009-04-23
US7326703B2 (en) 2008-02-05
EP1778696A2 (en) 2007-05-02
KR20070015547A (ko) 2007-02-05
ATE389660T1 (de) 2008-04-15
CN1950380B (zh) 2010-12-08
WO2005105810A2 (en) 2005-11-10
BRPI0510612A (pt) 2007-10-30
IL178082A0 (en) 2006-12-31
JP2007536346A (ja) 2007-12-13
MXPA06012755A (es) 2007-01-16
WO2005105810A3 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
NO20072235L (no) HCV-hemmende bicykliske pyrimidiner
WO2001029037A3 (en) Condensed naphthyridines as hiv reverse transcriptase inhibitors
NO20054905L (no) 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
MY146669A (en) Pyrazole derivatives for treating hiv
NO20065582L (no) (1,lOB-dihydro-2-(amtnokarbonyl-fenyl)-SH-pyrazolo[1,5-C][1,3]benzoksazin-5-yl)fenylmetanonderivater som HIV-virusreplikasjonsinhibitorer
TW200612898A (en) Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
NO20082530L (no) Imidazopyraziner som proteinkinaseinhibitorer
WO2021262826A3 (en) 1'-cyano nucleoside analogs and uses thereof
NO20045677L (no) Inhibitorer av JAK- og CDK2-proteinkinaser
NO20073140L (no) Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser
ATE494373T2 (de) Verfahren und zusammensetzungen zur verringerung von hcv virusgenommengen in einer zielzelle
NO20082092L (no) Pyrazolopyrimidiner som proteinkinaseinhibitorer
NO20010743L (no) Antivirale indoloksoacetyl-piperazin-derivater
BRPI0408704A (pt) benzil-piridazinonas como inibidores de transcriptase reversa
UY26758A1 (es) Agentes antivirales de imidazopiridina e imidazopirimidina
BRPI0408767A (pt) inibidores de transcriptase reversa não-nucleosìdeos i para o tratamento de doenças mediadas pelo hiv
TW200710091A (en) (1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
BRPI0414948A (pt) derivados de pirazolo-e-imidazo pirimidina
WO2005041951A3 (en) Rhodanine derivatives for use as antiviral agents
NO20065898L (no) 1-heterocyklyl-1,5-dihydro-pyrido[3,2-b]indol-2-oner
YU62504A (sh) Triciklična 2-pirimidonska jedinjenja korisna kao inhibitori hiv reverzne transkriptoze
EA200400690A1 (ru) Нуклеозиды, их препараты и их применение в качестве ингибиторов вирусных рнк-полимераз
BR0314860A (pt) Derivados de pirazol
BR0208987A (pt) Composto tricìclicos úteis como inibidores de transcriptase reserva de hiv
WO2004002410A3 (en) 2,4-disubstituted-pyridine n-oxides useful as hiv reverse transcriptase inhibitors